Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Granular cell ameloblastoma. An immunocytochemical study

R Dina1, C Marchetti, G Vallania

  • 1Section of Anatomic Pathology, University of Bologna, Bellaria Hospital, Italy.

Pathology, Research and Practice
|June 1, 1996
PubMed
Summary

Granular cell ameloblastoma exhibits unique cellular characteristics. Immunocytochemistry reveals granular cells are positive for CD68, indicating lysosomal overload and aiding tumor differentiation.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkers.

NPJ precision oncology·2026
Same author

PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey.

ESMO open·2025
Same author

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor response.

ESMO open·2025
Same author

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study.

ESMO open·2025
Same author

Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study.

ESMO open·2025
Same author

BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study.

ESMO open·2025

Area of Science:

  • Oral Pathology
  • Tumor Biology
  • Immunohistochemistry

Background:

  • Granular cell ameloblastoma is a rare odontogenic tumor.
  • The origin and nature of granular cells within these tumors remain debated.
  • Distinguishing granular cell ameloblastoma from other tumors with granular changes is clinically important.